Theyre delicate and typically require refrigeration or specific stabilization to be effective
Most side effects are transient and improve after 8-12 weeks
Tesamorelins strongest evidence is for visceral fat specifically, which is the metabolically active fat that surrounds organs in the abdominal cavity
usually improves over several weeks Diarrhoea or constipation : Altered bowel habits due to delayed gastric emptying Abdominal discomfort : Bloating, dyspepsia, or gastro-oesophageal reflux symptoms Practical management strategies recommended by NICE and specialist diabetes services include: Starting at the lowest licensed dose and titrating gradually according to the product's summary of product characteristics Eating smaller, more frequent meals and avoiding high-fat foods Maintaining adequate hydration, particularly if experiencing vomiting or diarrhoea Taking the injection at a consistent time as specified in the SmPC for your particular medication Less common but important adverse effects include: Injection site reactions : Rotate injection sites systematically between abdomen, thigh, and upper arm to minimise localised reactions Hypoglycaemia : Risk increases when GLP-1 agents are combined with insulin or sulphonylureas
There is a global need to identify new ways to maximize the well-being of individuals with SCD, and nutritional interventions could possibly play a pivotal role
They are not claims of safety, effectiveness, or suitability for human or veterinary use
